Huntington disease (HD) is an adult onset neurodegenerative disorder that is caused by the expansion of a polyglutamine tract within the huntingtin (htt) protein. Wild-type htt has been shown to be involved in transcription, transport and cell survival. Here we demonstrate that increased expression of full-length wild-type htt in mice is associated with a dose-dependent increase in body weight which results from an increase in both total fat mass and fat-free mass. Conversely, we show that a reduction in the levels of wild-type htt is associated with decreased body weight. Examination of individual organ weights revealed that the weight of the heart, liver, kidneys, lungs and spleen increased with the over-expression of wild-type htt while the brain and testis were unaltered. Based on these initial findings, we examined mice that over-express full-length mutant htt to determine the effect of polyglutamine expansion on this novel function of wild-type htt.
INTRODUCTION
Huntington disease (HD) is an adult onset neurodegenerative disorder caused by a CAG expansion in the HD gene which codes for the huntingtin (htt) protein. The disease is postulated to result from a gain of toxic function in the mutant htt protein combined with a loss of wild-type htt function (1, 2) . As a result of the CAG expansion, HD patients heterozygous for the disease mutation have levels of wild-type htt that are decreased by 50% from birth while HD patients homozygous for CAG expansion do not express wildtype htt at all. Accordingly, it is important to define the normal functions of the wild-type protein and to determine how these functions are modulated by polyglutamine expansion.
Htt is essential for embryonic development and normal function in adult mice (see (3) for review of normal huntingtin function). Mice homozygous for a targeted inactivation of the mouse HD gene die as embryos at day E8.5 (1, 4, 5) while mice heterozygous for the targeted inactivation of the mouse HD gene show behavioural abnormalities and neuronal loss (1, 6) . As htt levels are decreased below 50% of normal, the phenotypic abnormalities become more severe, manifesting in gross brain abnormalities and early death (7, 8) . The continued importance of htt function in adulthood is indicated by the neurologic phenotype that results from the inactivation of htt expression in mature mice (9) .
Wild-type htt appears to be involved in cellular survival, transcription and intracellular transport. Wild-type htt has been shown to protect neurons from toxic insults both in vitro and in vivo (10) (11) (12) (13) (14) . Htt has also been shown to interact with several transcription factors (15) and to specifically increase the transcription of genes under the control of a neuron restrictive silencer element (NRSE) including BDNF (16, 17) . The interaction of htt with multiple proteins involved in trafficking and endocytosis (15) suggests a role for htt in intracellular transport. This is supported by functional evidence demonstrating that htt facilitates fast axonal transport of vesicles and mitochondria within the cell (18) (19) (20) (21) .
While polyglutamine expansion disrupts many assayable functions of wild-type htt (10, 14, 16, 20) , even highly expanded mutant htt is able to rescue mice homozygous for at Pennsylvania State University on February 23, 2013 http://hmg.oxfordjournals.org/ Downloaded from the targeted inactivation of the mouse HD gene from embryonic lethality (12, 22, 23) . This suggests the possibility that some of the most critical functions of htt are not disrupted by polyglutamine expansion and may be unknown. This concept is supported by studies that show that the loss of wild-type htt in mouse models of HD results in only mild exacerbation of HD-like phenotypes (23) (24) (25) .
We have previously generated mice that over-express full-length wild-type htt in order to study htt function (26) . These YAC18 mice express human htt, with 18 glutamines, under its endogenous regulatory elements and show the same pattern of tissue specific htt expression as WT mice. These mice were used to demonstrate the neuroprotective function of wild-type htt (13, 14) . Similarly, we have generated YAC128 mice which express full-length mutant htt with 120 glutamines in order to study how htt function is affected by polyglutamine expansion (27) . These mice recapitulate the motor, cognitive and neuropathological abnormalities of HD (27, 28) . In this study, we find that the levels of full-length htt influence body weight in both YAC18 and YAC128 mice. 
RESULTS

Increased expression of wild-type huntingtin results in increased body weight in a dose dependent manner
We previously generated two lines of YAC18 mice to study wild-type htt function. The B60 line expresses low levels of wild-type htt while line 212 expresses wild-type htt at about 2-3 times endogenous levels (26) . Examination of these mice for overt phenotypes resulting from the over-expression of wild-type htt revealed that aged YAC18 mice were physically larger than WT mice. To quantify this difference, we monitored body weight in a cohort of mice from 2 to 11 months of age and found that total body weight increased with full-length htt expression (genotype: F (2,36) = 18.2, p < 0.001). Line 212 mice weighed significantly more than line B60 mice and line B60 mice weighed significantly more than WT mice ( YAC18, line 212: 0.27 ± 0.03 g/ week, p = 0.09). Western blotting for htt expression in whole brain lysates confirmed that line B60 mice express more wild-type htt than WT mice and line 212 mice express more wild-type htt than line B60 mice (Fig 1B) . Thus, higher levels of htt expression are associated with increased body weight. The demonstration of dose-dependent increases in total body weight in two different lines of YAC18 mice indicates that the increased weight is not a result of the site of integration and suggests the possibility that altered htt levels are causative of this finding.
To further test the hypothesis that wild-type htt influences body weight, we sought to determine if decreasing the levels of wild-type htt would result in decreased body weight.
Our laboratory has generated mice heterozygous for the targeted inactivation of the mouse HD gene (Hdh +/-mice) that express htt protein at half of wild-type levels (1). We examined the weight of a cohort of WT and Hdh +/-mice from 2 to 11 months of age and found that Hdh +/-mice weigh significantly less than WT mice beginning before 2 months of age (Fig 1C; 2 months -WT: 24.1 ± 0.4 g, Hdh +/-: 21.0 ± 0.8 g, p = 0.003).
While the difference was maintained until 11 months of age, the difference appeared to be greatest closer to two months of age suggesting that the difference in weight may stem from altered development in Hdh +/-mice (genotype: F (1, 20) = 4.2, p = 0.05). This is supported by the fact that the slopes of the weight gain graphs are similar from 2 to 11 months of age (Slope 2-12 months -WT: 0.26 ± 0.02 g/week, Hdh +/-: 0.23 ± 0.02 g/week, p = 0.3). Western blotting for htt protein in brain confirmed that Hdh +/-mice express htt at half of wild-type levels (Fig. 1D ). In combination with our findings in mice over-expressing wild-type type htt, it is clear that expression levels of full-length wildtype htt influence body weight.
Increased expression of wild-type huntingtin results in increased peripheral organ weights
In order to investigate the underlying cause of increased body weight in YAC18 mice, we measured organ weights in 12 month old YAC18, line 212 mice. We found that organ weight was significantly increased in YAC18 mice compared to WT mice in the heart, liver, lungs, kidneys and spleen ( Fig. 2A ; Heart -WT: 187 ± 4 mg, YAC18: 231 ± 7 mg, p < 0.001; Liver -WT: 1.94 ± 0.06 g, YAC18: 2.59 ± 0.11 g, p < 0.001; Lungs -WT: 420 ± 12 mg, YAC18: 485 ± 15 mg, p = 0.002; Kidneys -WT: 673 ± 13 mg, YAC18: 848 ± 26 mg, p < 0.001; Spleen -WT: 108 ± 2 mg, YAC18: 147 ± 11, p = 0.002). The increases in organ weight were seen in both male and female mice with similar magnitude except in the spleen where the percentage increase was greater in males (see supplementary figure 1 ). In contrast to all of the other organs tested, the brain and testis show no increase in weight ( Fig. 2A ; Brain -403 ± 3 mg, YAC18: 407 ± 4 mg, p = 0.4; Testis -WT: 161 ± 4 mg, YAC18: 152 ± 7 mg, p = 0.3). It is noteworthy that the organs were not grossly edematous, nor were there pericardial, pleural or peritoneal effusions.
We also examined the organs from YAC18 mice for gross pathology and compared these sections to those from WT mice. In sections from the liver, heart, spleen, kidneys and lungs of YAC18 mice the cytoarchitecture and histologic appearance was normal (see supplementary figure 1 for sample sections). We found no evidence of abnormal pathology including no accumulations of vacuoles or lipids, no increased extracellular matrix deposition and no infiltration of tissues by inflammatory or other cells. Next, we examined the level of htt expression in each of the organs studied to see if there was any correlation between the relative increases in weight and the level of htt expression. We found that, as previously reported, expression of full-length htt was highest in the brain and testis (Fig. 2B,C ; Htt expression as percentage of brain -Brain: 100 ± 11%, Heart: 10 ± 7%, Liver: 34 ± 15%; Lungs: 70 ± 21%; Kidney: 0 ± 2%; Spleen: 79 ± 16%; Testis: 110 ± 9%). Among the remaining peripheral tissues htt expression was highest in the lungs, which showed very little increase in weight, and the spleen, which showed the largest increase in weight in male mice. We were unable to detect any fulllength htt in the kidneys. Thus, while overall body weight increases with htt expression, increases in organ weight do not appear to be directly correlated with the level of htt expression in each organ. In fact, the brain and testis express the highest levels of htt yet neither show any increase in weight.
To determine whether the increases in organ weight resulted from an increase in cell number, we measured the volume and nuclear density of the liver and kidney. As expected from the increase in weight, the volumes of organs from YAC18 mice were significantly larger from WT mice (Kidney -WT: 938 ± 49 mm 3 , YAC18: 1281 ± 54 mm 3 , p < 0.001; Liver -WT: 2375 ± 72 mm 3 , YAC18: 3054 ± 82 mm 3 , p < 0.001).
Using counts of nuclei as an estimate of cell number, we found that there were also significantly more cells in the YAC18 organs than in WT organs (Kidney -WT: 360 ± 21 million nuclei, YAC18: 457 ± 23 million nuclei, p = 0.01; Liver -WT: 369 ± 32 million nuclei, YAC18: 494 ± 34 million nuclei, p = 0.02).
Similar to wild-type huntingtin, mutant huntingtin expression increases body weight and organ weight except in the brain and testis
Since many functions of wild-type htt are disrupted by polyglutamine expansion, we examined the effect of mutant htt over-expression on weight to determine how this (23, 27) . As in the YAC18 mice, we found that YAC128 mice show significantly increased body weight compared to WT mice from 2 to 11 months of age ( To determine whether the expression of an N-terminal fragment of htt is sufficient to increase weight, we examined body weights of shortstop mice at 12 months of age.
Shortstop mice express exons 1 and 2 of mutant htt with approximately 120 glutamines from the same YAC as YAC128 mice (29) . Importantly, shortstop mice express the mutant htt fragment at levels that are greater than the expression level of full-length mutant htt in YAC128 mice. We found that the weight of shortstop mice was equivalent to that of WT mice (WT: 37.8 ± 1.2 g, Shortstop: 36.4 ± 1.6 g, p = 0.5). The absence of weight increase in these mice was not a result of toxicity of the short mutant htt fragment as shortstop mice do not show any neurodegeneration (29) .
We have previously shown atrophy of the brain and testis of YAC128 mice resulting from mutant htt expression (23, 27) . To determine the effect of the expression of fulllength mutant htt on organ weights, we weighed organs from perfused, 12 month old YAC128 mice. Both the brain and testis showed significant atrophy in YAC128 mice compared to WT mice ( Fig. 4A ; Brain -WT: 400 ± 3 mg, YAC128: 386 ± 3 mg, p < 0.001; Testis -WT: 161 ± 4 mg, YAC128: 126 ± 8 mg, p < 0.001). In contrast, the heart, liver, kidneys and spleen from YAC128 mice all weighed significantly more than from WT mice suggesting a lack of toxicity in these organs ( Fig. 4A ; Heart -WT: 183 ± 4 mg, YAC128: 216 ± 3 mg, p < 0.001; Liver -WT: 1.90 ± 0.06 g, YAC128: 2.34 ± 0.06 g, p < 0.001; Kidneys -WT: 655 ± 15 mg, YAC128: 807 ± 12 mg, p < 0.001; Spleen -WT:
106 ± 2 mg, YAC128: 132 ± 4 mg, p < 0.001). While the magnitude of the changes differed in some cases, both male and female YAC128 mice showed increased organ weights compared to WT mice (see supplementary figure 2). As with the organs from YAC18 mice, these organs were not grossly edematous and microscopic examination of sections from the heart, liver, kidneys, lungs and spleen revealed no obvious pathology.
There was no accumulation of vacuoles or lipids, no alterations in extracellular matrix deposition and no infiltration of tissue by inflammatory cells.
In order to gain insight into why mutant htt caused atrophy in the brain and testis but increased the weight of the heart, liver, kidneys and spleen, we examined mutant htt expression in each of the organs to see if there was a correlation between mutant htt expression and either weight gain or toxicity. We found that mutant htt was most highly expressed in the brain and testis, thereby providing a possible explanation for why these two organs showed atrophy ( Fig. 4B,C ; Htt expression as percentage of brain -Brain: 100 ± 4%, Heart: 9 ± 2%, Liver: 29 ± 6%; Lungs: 13 ± 7%; Kidney: 0 ± 0%; Spleen: 20 ± 6%; Testis: 52 ± 5%). Among the remaining tissues mutant htt expression was highest in the liver, spleen and lungs (Fig. 4B,C ). We were unable to detect any full-length mutant htt in the kidney of YAC128 mice (Fig. 4B,C) . As in YAC18 mice, increases in htt expression did not correlate with increases in organ weight but toxicity was observed in the two organs expressing the highest levels of mutant htt.
Huntingtin expression does not affect food consumption
To further characterize the weight gain phenotype in YAC18 and YAC128 mice and also to determine whether the underlying mechanism is similar in these two transgenic mice, we examined the food consumption and weight change in 3 month old animals, when the differences in growth rate appeared to be most pronounced. Based on previous reports in the R6/2 mouse model of HD showing increased fat accumulation (30,31), we also examined body composition. Finally, we completed a fasting-refeeding experiment as a basic measure of metabolic rate (32).
We found that YAC18 mice gained weight more rapidly than WT mice ( Fig. 5A; genotype -F (1, 14) = 31.9, p < 0.001). However, during this period, food consumption per gram of lean body mass was not significantly different between the genotypes ( Fig. 5B; genotype -F (1, 14) = 0.3, p = 0.6). During a 24 hour fast, the body weight of YAC18 mice did not decrease at a faster rate than WT mice, suggesting that the metabolic rates are not different (Fig. 5C ). The rate of weight recovery following the 24 hour fast was also similar between WT and YAC18 mice (Fig. 5C ) and as a result the percentage of lost weight that was recovered did not differ between the genotypes.
Following full recovery of body weight, we performed body composition scans to determine what percentage of the weight increase was accounted for by increases in lean weight and fat accumulation (a sample scan is shown in supplementary figure 3 ). We found that both fat-free mass and total fat mass were significantly increased in YAC18 mice compared to WT ( Fig. 5D ; Fat-free mass: genotype -F (1,18) = 11.0, p = 0.004; total fat mass: genotype -F (1,18) = 19.0, p < 0.001). At this age, the organ weights in YAC18 mice were already significantly greater than in WT mice (not shown).
To determine the effect of polyglutamine expansion on the weight gain phenotype, we completed the same analysis in YAC128 mice. In contrast to the YAC18 mice, we observed that YAC128 mice did not gain weight more rapidly than WT mice relative to their body weight ( Fig. 6A ; genotype -F (1, 14) = 0.19, p = 0.7). As with the YAC18 cohort, there was no difference between the genotypes in food consumption during this period (Fig. 6B , genotype -F (1,14) = 2.7, p = 0.1). There was also no significant difference in the rate of weight loss during a 24 hour fast or weight gain afterwards between the YAC128 and WT mice (Fig. 6C) .
DISCUSSION
Wild-type htt has been shown to function in neuroprotection, transcription and transport within the cell (10, 16, 20) . Here we demonstrate a novel function of wild-type htt. We
show that over-expression of full-length wild-type htt is associated with a dose-dependent increase in body weight as both the fat-free mass and total fat mass are increased in YAC18 mice. This increase does not appear to result from increased food consumption or decreased metabolic rate. Examination of YAC128 mice revealed that the expression of full-length mutant htt also results in increased body weight. The increased weight in YAC128 mice did not appear to result from increased food consumption or decreased metabolism. In contrast to YAC18 mice, most of the difference in weight resulted from an increase in the total fat mass. Similarly, an increase in fat accumulation has been reported in R6/2 mice which express an N-terminal fragment of mutant htt (30) .
Increasing expression of full-length htt also resulted in increased organ weights with the exception of the brain and testis, the two organs that express the highest levels of htt (33) .
A possible explanation for this is that the high levels of htt present in the brain and testis are already sufficient for maximum growth and that additional htt has little impact.
Interestingly, over-expression of full-length mutant htt also resulted in increased organ weights except in the brain, testis and lungs. In agreement with our previous findings mutant htt expression in the brain and testis resulted in significant atrophy compared to WT mice (12, 23, 27) . The apparent toxicity of mutant htt in the brain and testis may result from high expression of mutant htt in these two organs and or an increased sensitivity to the effects of polyglutamine toxicity. It is also possible that these two organs are more affected because they are more dependent on wild-type htt function (33) . While fulllength htt expression resulted in a dose-dependent increase in total body weight, there was no correlation between htt expression levels in organs and their relative increase in weight with htt over-expression. The levels of full-length htt varied widely between organs yet, aside from the lungs, the increases in organ weights were roughly proportional to the increase in total body weight. This suggests the possibility that the increase in organ weight results from a central mechanism perhaps originating in the brain. Support for the levels of htt in brain affecting body weight comes from the fact that mice with reduced levels of wild-type htt in the adult forebrain show decreased weight (9) .
The activity of wild-type htt in transcription (16, 17) , transport (20) and neuroprotection (10, 12) are all disrupted by polyglutamine expansion and polyglutamine expansion also alters htt's interaction with most htt interacting proteins (15) . Since many of the functions of wild-type htt have been defined by their loss in mutant htt, it follows that most known functions of wild-type htt are disrupted by polyglutamine expansion. The fact that mutant htt can rescue mice homozygous for the targeted inactivation of the mouse HD gene from embryonic lethality (12, (22) (23) suggests that the most critical functions of wild-type htt in development must be maintained in mutant htt. If the mechanism of weight increase is similar between YAC18 and YAC128 mice, it is possible that the effect of wild-type htt on weight represents one of these critical functions. In order to identify additional functions of wild-type htt it will be important to carefully characterize mice overexpressing wild-type htt in addition to defining those functions that are lost through polyglutamine expansion.
Our work and previous studies in mouse models support a role of htt in determining body
weight. Here we demonstrate that a 50% reduction in wild-type htt levels resulted in a decrease in body weight. Similarly, mice with severely reduced htt levels in adulthood show a 20% decrease in body mass with proportional decreases in organ weight (9).
Chimeric mice, in which 20-75% of cells do not express wild-type htt, show decreases in body mass as great as 40% (34) . Mice expressing only 10-20% levels of endogenous htt have also been shown to have markedly decreased weight compared to controls (8) . Thus, it is clear that decreases in wild-type htt expression are associated with decreased body weight. As we have previously shown that decreasing wild-type htt levels in culture results in decreased cellular proliferation, a similar decrease in proliferation in vivo may contribute to the observed decreases in weight (35) . A role for htt altering cell proliferation is supported by the increase cell numbers we observe in the liver and kidneys of YAC18 mice compared to WT mice.
Weight loss has also been reported in mouse models of HD. Two mouse models expressing a small N-terminal fragment of mutant htt have demonstrated progressive weight loss that precedes premature death (36, 37) . In one of these models, the transgenic expression of a mutant htt fragment resulted in the depletion of full-length wild-type htt beginning at 7 weeks of age which is followed closely by a decrease in body weight at 8
weeks (38) . This finding suggests the possibility that decreasing levels of full-length htt in HD may contribute to the characteristic weight loss observed in late stages of the disease. Weight loss has also been demonstrated in a knock-in model of HD with 150 CAG repeats (25) .
In contrast, weight loss has not been reported in transgenic mouse models of HD which express full-length mutant htt (22, 27, 39) . These mice express two copies of full-length wild-type htt as well as one or more copies of full-length mutant htt. As a result, there is an over-expression of total full-length htt and we show here that both wild-type and mutant full-length htt act to increase body weight. We also show here that shortstop mice, expenditure does not account for differences in weight (44) . It has also been suggested that mitochondrial dysfunction in HD leads to increased energy expenditure and decreased weight (45) . However, sleeping metabolic rates of HD patients and unaffected individuals were not different suggesting that mitochondrial defects may not increase the basal metabolic rate in HD patients (44) .
The clear impact of full-length htt expression on body weight that has been demonstrated here and elsewhere suggests the possibility that decreased levels of full-length htt contribute to weight loss in HD. At birth, HD patients express decreased levels of fulllength wild-type htt by virtue of replacing one or both wild-type alleles with a mutant allele. While full-length mutant htt is expressed in its place, our results suggest that wildtype htt has a greater impact on fat-free mass. An increased effect of wild-type htt on body weight is supported by the fact that mice expressing one copy of mutant htt and one copy of wild-type htt weigh more than mice expressing two copies of mutant htt (25) .
Furthermore, mutant htt mRNA has been shown to be expressed at lower levels than wild-type htt mRNA (46) . In addition, the levels of total full-length htt are thought to be decreased during the course of the disease through aggregation and increased proteolysis.
In support of this, decreased levels of full-length htt have been demonstrated in the striatum of HD patients (47) and have been shown to precede weight loss in a mouse model of the disease (38, 48) . While further experiments will be required to elucidate the precise mechanism of weight loss in HD, our data suggests the possibility that a decrease in the levels of full-length mutant or wild-type htt may contribute to this phenotype.
Regardless, we demonstrate clearly that expression levels of full-length htt influence body weight in a dose-dependent manner.
MATERIALS AND METHODS
Mice
Experiments were carried out on YAC18 and YAC128 mice generated to express wildtype htt with 18 glutamines and mutant htt with 120 glutamines respectively (26, 27) . We also examined mice heterozygous for the targeted inactivation of the mouse HD gene (1).
All mice were maintained on the FVB/N strain background (Charles River, Wilmington, MA) and group housed with littermates of mixed genotype. Mice were kept on a normal light/dark cycle where lights were turned off at 8:00 PM and on at 6:00 AM.
Experimenters were blind to the genotype of the mice. For longitudinal measurement of body weight in YAC18 mice we used 5 female WT, 4 male WT, 9 female YAC18, line 
Body Weights and Organ Weights
Body weights were taken at 9:00 AM every two weeks from 2 to 11 months of age. At 12 months of age mice were perfused with 3% paraformaldehyde. All of the mice were perfused for exactly 10 minutes under a constant flow of 5 ml/min in order to ensure equivalent perfusion. Following perfusion, the organs were checked for firmness and loss of colour to confirm adequate perfusion. Subsequently, the organs were dissected out carefully by the same experimenter for each mouse in order to ensure consistency. The feeder blood vessels were trimmed to the junction with the organ parenchyma and all fat associated with the organs was removed. After excision and trimming the organs were post-fixed overnight in perfusate and equilibrated in phosphate buffered saline for 48
hours. Prior to weighing, organs were blotted thoroughly on kimwipes with gentle pressure until the organs were dry enough not to dampen a dry area of kimwipe under mild pressure. In the case of the heart and lungs additional pressure was applied to ensure that no solution was trapped in the cavities.
Organ volumes were determined by volume displacement in a graduated cylinder filled with water. Prior to measurement, the organs were dried thoroughly as described above.
Counts of nuclei were performed using Stereoinvestigator stereology software (Microbrightfield, Williston, Virginia). 10 µm sections were cut on a cryostat (Microm HM 500M, Richard-Allan Scientific, Calamazoo, Michigan) and mounted directly onto slides. Sections were stained with toluidine blue (water for 1 minute, toluidine blue for 3 minutes, 3 washes with water for 1 minute, 5 dips in 95% ethanol, 5 dips in 100%
ethanol, 30 seconds in xylene). Sections of liver and kidney were outlined and nuclei were counted in a 25 µm X 25 µm counting frame with a grid size of 800 µm X 800 µm.
Cell number was estimated by multiplying nuclear density by organ volume and dividing by the volume of the counting frame.
Organs were also analyzed for gross pathology. 10 µm cryostat sections were stained with cresyl violet (70% ethanol for 2 minutes, water for 2 minutes, cresyl violet for 5 minutes, 2 dips in water, 2 dips in 70% ethanol with 1% glacial acetic acid, 2 dips in 100% ethanol with 1% glacial acetic acid, 100% ethanol for 1 minute, xylenes for 1 minute) and examined under the microscope. We specifically looked for accumulations of vacuoles or lipids, increased extracellular matrix deposition and infiltration of tissues by inflammatory or other cells.
Western Blots
Western blots were performed on tissue samples frozen immediately after mice were asphyxiated with carbon dioxide. Protein lysates containing 100 µg of total protein were separated on a 7.5% acrylamide gel. Following transfer to a membrane, htt protein was detected using the htt-specific MAB2166 antibody (1:2000, 1 hour, room temperature;
Chemicon, Temecula, CA) followed by incubation with a peroxidase-linked anti-mouse secondary antibody (1:5000) and enhanced chemiluminescent (ECL) detection. Protein levels were quantified by measuring band density with Quantity One software (BioRad, Hercules, CA).
Feeding Experiments
Feeding and weight gain were monitored in 3 month old YAC18 mice, YAC128 mice and WT littermates controls. Mice were singly housed for these measurements. Mice and food were weighed twice a week for a period of approximately 6 weeks. In addition to weighing the food remaining in the hopper, the bedding was visually inspected for food particles that had been spilled or buried by the mice. These particles were added back to the leftover food prior to weighing. Female mice under these conditions were stressed and showed fluctuations in weight. Accordingly, we only analyzed data from male mice.
For the YAC18 comparison, we examined 4 WT mice and 6 YAC18 mice while the YAC128 comparison used 8 WT mice and 7 YAC128 mice. After 6 weeks, mice were fasted for 24 hours and the weight lost during that period was used to estimate their metabolic rate. The mice were then given free access to food and the weight of the mice was measured after 24 hours as a measure of their ability to recover.
One week after measuring food consumption, the body composition of the mice was determined by nuclear magnetic resonance (NMR) imaging. Briefly, whole body fat measurements have been carried out on a 7T animal MRI scanner (Bruker, Germany).
Awake mice were placed inside a restrainer, and the restrainer positioned inside the magnet. NMR signal from the entire body was acquired with a quadrature volume RF coil tuned to 300MHz. Standard CPMG sequence (TE = 2.377 ms, TR = 10 s) was used to acquire 256 echoes from which the T 2 decay curve was extracted. The decay curves were fit to a double exponential function using software procedure developed in house with Igor (WaveMetrics, OR). The component corresponding to T 2 ≈ 40 ms was identified as water in lean tissue, and the one with T 2 ≈ 200 ms as body fat (49) . The dc shift of the double exponential function was identified as a "free" water component corresponding to body fluids, e.g. urine and CSF, with the typical amounts of less than 5% of the total signal. The ratio of lean tissue/body fat expressed as weight/weight was calculated from the NMR data as described in (49) .
Statistical Analysis
Data are given as the mean ± standard error of the mean (SEM). Longitudinal measurements of weight and food consumption were analyzed by repeated measures ANOVA. Comparisons of single outcome measures were analyzed by one way ANOVA.
In case of significant differences between genotypes, post hoc comparisons between genotypes at individual points were assessed with a Student's t-test. 
